ENEIDA DE PINA: Open Payments
NPI 1528303468 · KEARNY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 16 payments from 10 companies in 2025. Trend: 2023 $223 · 2024 $289 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $98 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $57 |
| Exeltis, USA Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Organon LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| MILLICENT US INC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| CooperSurgical, Inc. | 1 | $15 |
Products named: Veozah, SLYND, Mirena, MYFEMBREE, NEXPLANON, SHINGRIX, FEMLYV, GARDASIL 9.
Industry payments across NJ — which companies pay providers there.
